Cargando…
MiR-181a functions as an oncogene by regulating CCND1 in multiple myeloma
MicroRNA-181a (miR-181a) has been demonstrated to be upregulated in patients with multiple myeloma (MM). In several studies, miR-181a has been demonstrated to be significantly overexpressed in MM; however, its potential role in development and progression of MM remains unknown. In the present study,...
Autores principales: | Yan, Xiao, Gao, Minjie, Zhang, Ping, Ouyang, Guifang, Mu, Qitian, Xu, Kaihong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286114/ https://www.ncbi.nlm.nih.gov/pubmed/32566002 http://dx.doi.org/10.3892/ol.2020.11579 |
Ejemplares similares
-
The expression and role of miR-181a in multiple myeloma
por: Yuan, Ruili, et al.
Publicado: (2018) -
Oncogenic MicroRNAs: miR-155, miR-19a, miR-181b, and miR-24 enable monitoring of early breast cancer in serum
por: Sochor, Marek, et al.
Publicado: (2014) -
miR-181c expression in neuroblastoma children and proliferation of neuroblastoma M17 cells
por: Xu, Xueyan, et al.
Publicado: (2019) -
Oncogenic miR-181a/b affect the DNA damage response in aggressive breast cancer
por: Bisso, Andrea, et al.
Publicado: (2013) -
miR-181a initiates and perpetuates oncogenic transformation through the regulation of innate immune signaling
por: Knarr, Matthew, et al.
Publicado: (2020)